Ayala Pharmaceuticals
Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.
About
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing novel small molecule therapeutics for patients with rare tumors and aggressive cancers. Their pipeline targets specific genetic alterations that drive tumor growth and resistance to existing therapies.
Show 6 more similar companies
Similar companies
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Therapeutics
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Therapeutics
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Therapeutics
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Omnix Medical is developing a novel platform for advanced wound care management.
Shares Life Sciences, HealthTech
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Ayala Pharmaceuticals?
People comparing tools land here. Get listed beside these.
Copy Ayala Pharmaceuticals's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- ayalapharma.com
- Headquarters
- Jerusalem, Israel
- Founded
- 2017
- Founder
- Roni Mamluk
- Total funding
- $72M (Series C)
- Business model
- B2B
Funding rounds
- $25M19 Feb 2021
- $30M28 May 2019Series BLargest round
Led by Novartis Venture Fund
- $17M11 Apr 2018
Led by Israel Biotech Fund
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 19 Feb 2021 | Series C | $25M | |
| 28 May 2019 | Series B | $30M | Novartis Venture Fund |
| 11 Apr 2018 | Series A | $17M | Israel Biotech Fund |
Tech stack
Detected on ayalapharma.com, last scanned 7 Nov 2026. Run your own scan
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Benchmarking
See how your site ranks against 16,849 startups
Ayala Pharmaceuticals sits in the 37th percentile for Domain Rating. Check where yours lands, free.
Ayala Pharmaceuticals has a Domain Rating of 30, the 37th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursAgent Readiness
Below median
Scan yoursSite Speed
Top 25%
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Ayala Pharmaceuticals scores 32. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Ayala Pharmaceuticals changes
Used Ayala Pharmaceuticals? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Who owns Ayala Pharmaceuticals?
Ayala Pharmaceuticals is privately held, owned by its founders and investors. Israel Biotech Fund has backed 2 of the 3 rounds on record since April 2018, ahead of aMoon (2) and Harel Insurance Investments and Financial Services (2), so it is likely among the largest outside shareholders. Exact stakes are not public.
Are there companies like Ayala Pharmaceuticals?
Yes. We list 6 companies like Ayala Pharmaceuticals, including Somite.ai, Upstream Bio and Mana.bio. Ayala Pharmaceuticals stands out on funding: its $72M is second only to Upstream Bio ($400M) among them.
Is Ayala Pharmaceuticals trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Ayala Pharmaceuticals is 63 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Ayala Pharmaceuticals raised?
Ayala Pharmaceuticals has raised a total of $72M in funding. The most recent round on record is Series C.
SEC filings, insider activity, nonprofit links and pay benchmarks for Ayala Pharmaceuticals:
Company details: from public sources. Funding: 3 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Ayala Pharmaceuticals and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

